Basilea Pharmaceutica
BSLN.SW
#5994
Rank
A$1.61 B
Marketcap
A$130.39
Share price
0.41%
Change (1 day)
42.85%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2025: A$86.92 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of A$86.92 Million a decrease over its 2024 earnings that were of A$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2025

Annual earnings

Year Earnings Change
2025A$86.92 M-13.15%
2024A$0.10 B436.2%
2023A$18.66 M-5.02%
2022A$19.65 M-276.18%
2021-A$11.16 Million-55.31%
2020-A$24.96 Million-28%
2019-A$34.67 Million-27.06%
2018-A$47.53 Million62.13%
2017-A$29.32 Million-60.94%
2016-A$75.04 Million-19.67%
2015-A$93.41 Million48.25%
2014-A$63.01 Million12.95%
2013-A$55.79 Million-35.16%
2012-A$86.04 Million-5.75%
2011-A$91.29 Million-152.57%
2010A$0.17 B-199.59%
2009-A$0.18 Billion-15.54%
2008-A$0.21 Billion22.84%
2007-A$0.17 Billion60.07%
2006-A$0.11 Billion85.69%
2005-A$56.55 Million-43.04%
2004-A$99.27 Million47.04%
2003-A$67.51 Million-37.04%
2002-A$0.11 Billion